New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients
Marianne Ryberg(University of Copenhagen), Per Kragh Andersen(University of Copenhagen), Giuliana Cortese(University of Padua), Dorte Nielsen(Herlev Hospital), Gitte Nielsen(University of Copenhagen), Torben Skovsgaard(Unknown)
Cited by 176
Related Papers
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
|Cancer Treatment Reviews|2013|328
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
|Journal of Clinical Oncology|1998|285
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
|BMC Pharmacology and Toxicology|2014|264